Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
| Quarterly Results |
------------------- in Rs. Cr. ------------------- |
 |
|
|
Sep '07 |
Dec '07 |
Mar '08 |
Jun '08 |
Sep '08 |
|
| Sales Turnover |
1,038.12 |
993.32 |
987.29 |
1,216.92 |
1,132.82 |
| Other Income |
115.32 |
124.79 |
87.68 |
107.48 |
15.28 |
| Total Income |
1,153.44 |
1,118.11 |
1,074.97 |
1,324.40 |
1,148.10 |
| Total Expenses |
905.68 |
1,011.21 |
974.69 |
1,244.31 |
1,047.36 |
| Operating Profit |
132.44 |
-17.89 |
12.60 |
-27.39 |
85.46 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
22.31 |
4.40 |
89.52 |
-- |
-244.14 |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
247.76 |
106.90 |
100.28 |
80.09 |
100.74 |
| Interest |
26.27 |
24.76 |
26.25 |
31.68 |
361.11 |
| PBDT |
243.80 |
86.54 |
163.55 |
48.42 |
-504.51 |
| Depreciation |
32.52 |
30.03 |
32.15 |
29.23 |
30.26 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
211.28 |
56.51 |
131.40 |
19.19 |
-534.77 |
| Tax |
43.12 |
8.11 |
27.98 |
-4.54 |
-181.84 |
| Net Profit |
168.16 |
48.40 |
103.42 |
23.73 |
-352.93 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
4.51 |
1.30 |
2.77 |
0.64 |
-- |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
186.48 |
186.54 |
186.54 |
186.62 |
187.04 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
|
| Source : Asian CERC |
|
Online
